Gossage on PED users in the Hall: "I really don't know what we'd do"

29 Comments

Goose Gossage.jpgSo earlier I asked if someone had Rich Gossage’s cell.
Seems someone did, and I just got off the phone with the Goose.  Nicest
guy in the world, by the way. If you’re going to talk to a Hall of Fame
reliever today, I highly recommend that you make it Gossage.

Anyway, the reason I called him was because I wanted to know, in light of his feelings on Mark McGwire and other steroid users,
what he’d think if Jose Canseco was proven right and we found out that
a current member of the Baseball Hall of Fame used performance
enhancing drugs. And Gossage was honest: he has no idea.

“I don’t really know what I’d do,” Gossage said.  “We’d have to find
out all the facts,” he said. “It’s a big dark cloud. I don’t know what
the scenario would look like.”

Gossage went on to say that it would probably depend on what the
writers did going forward with steroid users like Barry Bonds and Roger
Clemens — guys who are sure shot Hall of Famers if they hadn’t used. 
“If they let in some of those guys, I guess things are different.  What
I said about integrity yesterday still stands, but as for the Hall,
we’d have to see how the writers handled it. I can only speak for what
I believe.”

Gossage wouldn’t speculate about whether it would be appropriate to
remove someone from the Hall of Fame.  And though I didn’t ask him, he
volunteered that he has no idea what member, if any, could have
possibly used steroids, and doesn’t know one way or the other if anyone
had (he wouldn’t comment on the issue of Canseco’s credibility).

To date, no member of the Hall has ever been de-inducted, as it were,
and I could find nothing that suggests that the Hall even has a
procedure for doing so. Of course, if they wanted to, the Hall could
simply call a meeting of its board and make a rule in about five
minutes.  But let’s face it: if the Football Hall of Fame hasn’t taken
out O.J., what are the odds that the Baseball Hall of Fame would remove
a juicer?

But back to Gossage, who was gracious enough to chat with me a bit
longer than I thought he might:  He thinks that there’s a difference
between drugs of abuse and performance enhancing drugs.  He says “Dave
Parker was one of the top five baseball players I ever played with.” He
does not think that his — or Tim Raines or any other player’s —
cocaine use should be held against them in Hall of Fame voting. 
“Parker belongs,” he said. “What he did, with the cocaine, that
decreased his performance, it didn’t enhance it. If he hadn’t done that
stuff we wouldn’t be having this conversation.”  Gossage clearly thinks Parker would have been a first ballot Hall of Famer absent his mid-career cocaine-induced swoon.

“It all boils down to one word: integrity,” Gossage said.  “When it
comes to steroids, you have to talk about the records, and records are
something huge.  The home run record is the greatest record there is.”

I had to ask, of course: is Aaron still the home run king?  “In my mind
he is.  Not only was he the best. But look at where he came from. All
he did. That’s a Hall of Famer.”

I came away from our conversation with the impression that Goose
Gossage is a reasonable and level-headed guy when it comes to this
stuff. He believes what he believes, but he knows others disagree. 
He’s not out to moralize on the subject or tell others what to think.

It’s easy to get the opposite impression of the man, however, from
reading some of the reporting about him that we’ve seen in past couple
of years.  Some of that stuff has made him look like a fire-breather on
the subject of Hall of Fame standards in general and steroids in
particular. It’s enough to make one wonder if the writers who have
elicited all of those juicy quotes from him are trying to make him seem
more of a crusader than he really is.

To me he just seems sensible. But then again, he’s from Colorado, and I’ve never known anyone from Colorado who was anything but sensible.

Matt Wieters could draw interest from Reds

BALTIMORE, MD - SEPTEMBER 15: Matt Wieters #32 of the Baltimore Orioles looks on against the Tampa Bay Rays at Oriole Park at Camden Yards on September 15, 2016 in Baltimore, Maryland. (Photo by Patrick Smith/Getty Images)
Getty Images
Leave a comment

With the Braves on the cusp of formalizing their one-year deal with Kurt Suzuki, the market for free agent catcher Matt Wieters is dwindling. ESPN’s Jerry Crasnick references an inside source that lists the Angels, Rockies and Reds as potential suitors for the 30-year-old’s services.

Wieters is coming off of an eight-year career with the Orioles. In 2016, he played through his first full year after undergoing Tommy John surgery in 2014 and batted .243/.302/.409 with 17 home runs and a .711 OPS in 464 PA. A return to Baltimore in 2017 isn’t out of the question, Crasnick writes, citing some within the team that would be open to Wieters stepping into a DH role and catching platoon with Wellington Castillo. However, he also points out that the front office appears divided on the veteran catcher, and sees the Orioles as a long shot for the foreseeable future.

The Angels have already been tied to Wieters this offseason, while the Rockies and Reds don’t appear to have made any formal inquiries so far. Both could use a veteran presence behind the dish, as the Rockies are planning to platoon rookie catcher Tom Murphy with 24-year-old Tony Wolters in the spring. The Reds, meanwhile, are banking on a quick recovery for 28-year-old Devin Mesoraco, who missed most of the 2016 season after undergoing shoulder and hip surgery and forced the club to rely almost exclusively on back-up backstop Tucker Barnhart.

Red Sox could go to arbitration hearing with Fernando Abad

BOSTON, MA - SEPTEMBER 16:  Fernando Abad #58 of the Boston Red Sox pitches against the New York Yankees during the ninth inning at Fenway Park on September 16, 2016 in Boston, Massachusetts.  (Photo by Maddie Meyer/Getty Images)
Getty Images
2 Comments

The Red Sox are expecting to go to an arbitration hearing with left-handed reliever Fernando Abad, per Pete Abraham of the Boston Globe. Red Sox president Dave Dombrowski said there was a “decent chance” a hearing would be necessary after countering Abad’s $2.7 million request with $2 million.

Abad, 31, pitched just 12 2/3 innings for Boston after the club acquired him from Minnesota at the trade deadline last season. The lefty earned a cumulative 3.66 ERA, 4.2 BB/9 and 7.9 SO/9 for the two teams in 2016. He received $1.25 million in 2016 and will remain under club control (through arbitration) in 2017. A $2.7 million salary would be a hefty increase for the veteran reliever, who has seen a significant decline since he put up a 1.57 ERA for the Athletics in 2014 and who has not amassed more than 0.6 fWAR in any single season to date.

While the Red Sox aren’t close to settling with Abad, Evan Drellich of the Boston Herald reports that they may be closing in on a settlement with left-handed starter Drew Pomeranz. Pomeranz filed at $5.7 million, while the Sox felt more comfortable at $3.6 million. The two are expected to meet somewhere in the middle to avoid an arbitration hearing later this winter.